PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 250 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $897,000 | -43.2% | 12,800 | -51.5% | 0.01% | -45.5% |
| Q4 2020 | $1,580,000 | -0.4% | 26,400 | 0.0% | 0.01% | -8.3% |
| Q3 2020 | $1,587,000 | +177.4% | 26,400 | +142.2% | 0.01% | +140.0% |
| Q2 2020 | $572,000 | -74.7% | 10,900 | -79.0% | 0.01% | -73.7% |
| Q2 2019 | $2,257,000 | -21.1% | 51,900 | -31.0% | 0.02% | -26.9% |
| Q1 2019 | $2,862,000 | +11.6% | 75,200 | +26.2% | 0.03% | +13.0% |
| Q4 2018 | $2,564,000 | -26.4% | 59,600 | -15.9% | 0.02% | -11.5% |
| Q3 2018 | $3,485,000 | +44.6% | 70,900 | -5.7% | 0.03% | +23.8% |
| Q2 2018 | $2,410,000 | -7.1% | 75,200 | -9.7% | 0.02% | -16.0% |
| Q1 2018 | $2,595,000 | +426.4% | 83,300 | +671.3% | 0.02% | +525.0% |
| Q4 2017 | $493,000 | -82.6% | 10,800 | -85.7% | 0.00% | -84.6% |
| Q3 2017 | $2,839,000 | -21.3% | 75,600 | 0.0% | 0.03% | -25.7% |
| Q2 2017 | $3,606,000 | -50.6% | 75,600 | -52.8% | 0.04% | +2.9% |
| Q1 2017 | $7,296,000 | +83.0% | 160,000 | +29.7% | 0.03% | -29.2% |
| Q4 2016 | $3,986,000 | -6.2% | 123,400 | -0.6% | 0.05% | +4.3% |
| Q3 2016 | $4,250,000 | – | 124,200 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 550,000 | $18,442,000 | 6.98% |
| Gagnon Advisors, LLC | 193,860 | $6,500,000 | 6.06% |
| GAGNON SECURITIES LLC | 407,159 | $13,652,000 | 4.64% |
| Spyglass Capital Management LLC | 1,190,537 | $39,919,000 | 4.51% |
| Paulson & Co. | 1,716,727 | $57,562,000 | 2.20% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,627,521 | $54,571,000 | 1.73% |
| Elk Creek Partners, LLC | 265,146 | $8,890,000 | 1.53% |
| HealthCor Management, L.P. | 887,370 | $29,754,000 | 1.27% |
| Rock Springs Capital Management LP | 900,000 | $30,177,000 | 1.25% |
| Lisanti Capital Growth, LLC | 108,679 | $3,644,000 | 1.20% |